August 11th, 2008
FOR IMMEDIATE RELEASE
Sloan-Kettering Institute to Use GeneBio’s Phenyx Protein ID Platform
Geneva, Switzerland – August 12, 2008 - Geneva Bioinformatics (GeneBio) SA today
announced that the Sloan-Kettering Institute, part of the Memorial
Sloan-Kettering Cancer Center, has licensed GeneBio’s PhenyxServer protein
identification and characterization software to be used in the laboratory of
Paul Tempst, PhD.
Dr. Paul Tempst’s team is one of the five Clinical Proteomic Technology
Assessment for Cancer (CPTAC) teams, a collaborative network established by the
National Cancer Institute (NCI) whose goal is to enable all researchers
conducting cancer-related protein research at different laboratories to
effectively use proteomic technologies and methodologies to directly compare and
analyze their work.
Developed in collaboration with the Swiss Institute of Bioinformatics (SIB),
Phenyx is GeneBio’s comprehensive platform for protein identification and
characterization, including extensive PTM searches, results quantitation,
multiple results comparison, etc. Phenyx is specifically designed to meet the
concurrent demands of high-throughput MS data analysis and dynamic results
assessment while offering a flexible user experience and an adaptable
architecture to help instil confidence in results assessment. (http://phenyx.vital-it.ch/pwi)
“We are excited to see how Phenyx matches up with other search engines in the
lab and our various projects,” said Paul Tempst, Lab Head of the Protein Center
which is a part of the Molecular Biology Research Program at the Sloan-Kettering
Institute.
“We are happy to have signed on Dr. Tempst’s group as a Phenyx user,” said Nasri
Nahas, CEO of GeneBio. “The Phenyx platform adds great value due to its unique
capabilities and level of flexibility; we are excited to provide Paul’s team
with the best possible scoring schemes in order for them to truly take advantage
of their data within the framework of their Proteomics research studies.”
For more information concerning Phenyx, including product demonstrations, please
visit GeneBio’s booth (#103) at the upcoming HUPO 7th Annual World Congress in
Amsterdam, NL, from August 16-20.
About GeneBio
Geneva Bioinformatics (GeneBio) SA is a leading bioinformatics company providing
the life science community with world-class proteomics software that bridges the
gap between information gathering and knowledge generation. Established in 1997,
GeneBio focuses its expertise on protein identification and characterization as
well as proteome imaging, offering clients and partners a high degree of
specialization essential to proteomics research. Close ties to academic peers
and a thorough network of distribution and strategic partners give the company
both unfettered access to scientific excellence and recognized market presence
so that we may best serve the scientific community. For more information about
GeneBio, please visit: www.genebio.com.
GeneBio contact:
Mr. Andrew Smith
Marketing Manager
andrew.smith@genebio.com
Tel. +41 22 702 9900
###